Literature DB >> 32154959

Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.

Lindsay C Kobayashi1, Harvey Jay Cohen2, Wanting Zhai3, Xingtao Zhou3, Brent J Small4,5, George Luta6, Arti Hurria7, Judith Carroll8, Danielle Tometich9, Brenna C McDonald10, Deena Graham11, Heather S L Jim5, Paul Jacobsen12, James C Root13, Andrew J Saykin10, Tim A Ahles13, Jeanne Mandelblatt3.   

Abstract

OBJECTIVE: To investigate the relationships between self-reported and objectively measured cognitive function prior to systemic therapy and subsequent well-being outcomes over 24 months in older breast cancer survivors.
METHODS: Data were from 397 women aged 60 to 98 diagnosed with non-metastatic breast cancer in the Thinking and Living with Cancer Study recruited from 2010-2016. Cognitive function was measured at baseline (following surgery, prior to systemic therapy) using neuropsychological assessments of attention, processing speed, and executive function (APE), learning and memory (LM), and the self-reported FACT-Cog scale. Well-being was measured using the FACT-G functional, physical, social, and emotional well-being domain scales at baseline and 12 and 24 months later, scaled from 0 (low) to 100 (high). Linear mixed-effects models assessed the relationships between each of baseline APE, LM, and FACT-Cog quartiles with well-being scores over 24 months, adjusted for confounding variables.
RESULTS: At baseline, older survivors in the lowest APE, LM, and FACT-Cog score quartiles experienced poorer global well-being than those in the highest quartiles. At 24 months, older survivors tended to improve in well-being, and there were no differences according to baseline APE or LM scores. At 24 months, mean global well-being was 80.3 (95% CI: 76.2-84.3) among those in the lowest vs 86.6 (95% CI: 83.1-90.1) in the highest FACT-cog quartile, a clinically meaningful difference of 6.3 points (95% CI: 1.5-11.1).
CONCLUSIONS: Among older breast cancer survivors, self-reported, but not objective cognitive impairments, were associated with lower global well-being over the first 2 years of survivorship.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  aging; breast cancer; cancer; cancer survivors; cognitive function; oncology; quality of life; self-reports; well-being

Mesh:

Year:  2020        PMID: 32154959      PMCID: PMC7299808          DOI: 10.1002/pon.5376

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  35 in total

Review 1.  DNA damage, aging, and cancer.

Authors:  Jan H J Hoeijmakers
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

2.  Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.

Authors:  Kathleen Van Dyk; Aimee M Hunter; Linda Ercoli; Laura Petersen; Andrew F Leuchter; Patricia A Ganz
Journal:  Breast Cancer Res Treat       Date:  2017-07-13       Impact factor: 4.872

3.  Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer.

Authors:  Val Shilling; Valerie Jenkins
Journal:  Eur J Oncol Nurs       Date:  2006-07-17       Impact factor: 2.398

4.  Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.

Authors:  Arti Hurria; Enrique Soto-Perez-de-Celis; Jacob B Allred; Harvey Jay Cohen; Anait Arsenyan; Karla Ballman; Jennifer Le-Rademacher; Aminah Jatoi; Julie Filo; Jeanne Mandelblatt; Jacqueline M Lafky; Gretchen Kimmick; Heidi D Klepin; Rachel A Freedman; Harold Burstein; Julie Gralow; Antonio C Wolff; Gustav Magrinat; Myra Barginear; Hyman Muss
Journal:  J Am Geriatr Soc       Date:  2018-08-26       Impact factor: 5.562

Review 5.  Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research.

Authors:  Allison Magnuson; Heather Allore; Harvey Jay Cohen; Supriya G Mohile; Grant R Williams; Andrew Chapman; Martine Extermann; Rebecca L Olin; Valerie Targia; Amy Mackenzie; Holly M Holmes; Arti Hurria
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

6.  Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.

Authors:  Yin Ting Cheung; Yu Lee Foo; Maung Shwe; Yee Pin Tan; Gilbert Fan; Wei Sean Yong; Preetha Madhukumar; Wei Seong Ooi; Wen Yee Chay; Rebecca A Dent; Soo Fan Ang; Soo Kien Lo; Yoon Sim Yap; Raymond Ng; Alexandre Chan
Journal:  J Clin Epidemiol       Date:  2014-03-18       Impact factor: 6.437

7.  Cognitive functions in depressive disorders: evidence from a population-based study.

Authors:  E Airaksinen; M Larsson; I Lundberg; Y Forsell
Journal:  Psychol Med       Date:  2004-01       Impact factor: 7.723

8.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

9.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

Review 10.  Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline.

Authors:  Charissa Andreotti; James C Root; Tim A Ahles; Bruce S McEwen; Bruce E Compas
Journal:  Psychooncology       Date:  2014-10-06       Impact factor: 3.894

View more
  8 in total

1.  Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.

Authors:  Brent J Small; Marie Lange; Jeanne Mandelblatt; Florence Joly; Wanting Zhai; Jaeil Ahn; Tim A Ahles; Judith E Carroll; Harvey J Cohen; Deena Graham; Martine Extermann; Natacha Heutte; Heather S L Jim; Brenna C McDonald; Sunita K Patel; James C Root; Andrew J Saykin; Kathleen Van Dyk; Xingtao Zhou
Journal:  Breast Cancer Res Treat       Date:  2021-11-24       Impact factor: 4.872

2.  Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.

Authors:  Jeanne S Mandelblatt; Tim A Ahles; James C Root; Xingtao Zhou; Jaeil Ahn; Brent J Small; Wanting Zhai; Traci Bethea; Judith E Carroll; Harvey Jay Cohen; Asma Dilawari; Martine Extermann; Deena Graham; Claudine Isaacs; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Zev M Nakamura; Sunita K Patel; Kelly Rentscher; Andrew J Saykin; Kathleen Van Dyk
Journal:  Breast Cancer Res Treat       Date:  2022-05-19       Impact factor: 4.624

3.  Electroacupuncture for Cancer-Related Cognitive Impairment: A Clinical Feasibility Study.

Authors:  Yee Ran Lyu; Hye-Yoon Lee; Hyo-Ju Park; O-Jin Kwon; Ae-Ran Kim; In Chul Jung; Yang-Chun Park; Jung-Hyo Cho; Jung-Eun Kim; Mikyung Kim; Jun-Hwan Lee; Joo-Hee Kim
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

4.  Response to Dekker, Stege, and Versteeg.

Authors:  Jeanne S Mandelblatt; Xingtao Zhou; Brent J Small; Jaeil Ahn; Wanting Zhai; Tim Ahles; Martine Extermann; Deena Graham; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Sunita K Patel; James C Root; Andrew J Saykin; Harvey Jay Cohen; Judith E Carroll
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 13.506

5.  Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.

Authors:  Kathleen Van Dyk; Xingtao Zhou; Brent J Small; Jaeil Ahn; Wanting Zhai; Tim Ahles; Deena Graham; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Kelly Nudelman Holohan; Sunita K Patel; G William Rebeck; James C Root; Andrew J Saykin; Harvey Jay Cohen; Jeanne S Mandelblatt; Judith E Carroll
Journal:  JNCI Cancer Spectr       Date:  2021-01-27

6.  Extracellular Vesicle Proteome of Breast Cancer Patients with and Without Cognitive Impairment Following Anthracycline-based Chemotherapy: An Exploratory Study.

Authors:  Yong Qin Koh; Ding Quan Ng; Chiu Chin Ng; Adrian Boey; Meng Wei; Siu Kwan Sze; Han Kiat Ho; Munjal Acharya; Charles L Limoli; Alexandre Chan
Journal:  Biomark Insights       Date:  2021-05-24

Review 7.  Are Sleep Complaints Related to Cognitive Functioning in Non-Central Nervous System Cancer? A Systematic Review.

Authors:  Mylène Duivon; Bénédicte Giffard; Béatrice Desgranges; Joy Perrier
Journal:  Neuropsychol Rev       Date:  2021-08-05       Impact factor: 6.940

8.  Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.

Authors:  Kelly E Rentscher; Xingtao Zhou; Brent J Small; Harvey J Cohen; Asma A Dilawari; Sunita K Patel; Traci N Bethea; Kathleen M Van Dyk; Zev M Nakamura; Jaeil Ahn; Wanting Zhai; Tim A Ahles; Heather S L Jim; Brenna C McDonald; Andrew J Saykin; James C Root; Deena M A Graham; Judith E Carroll; Jeanne S Mandelblatt
Journal:  Cancer       Date:  2021-06-23       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.